CUKIERMAN & CO INVESTMENT HOUSE LTD
Cukierman, Cukierman & Co is the leading Israeli investment house, providing a full array of services including Mergers and Acquisitions (M & A), Private Placements, Public Offerings, and Consulting Services to Israeli, European and Asian clients. With over $7 billion in completed transactions and one of the largest Corporate Finance Teams in Israel, Cukierman and Co includes dedicated experts in fields including Life Sciences.
Cukierman and Co includes Catalyst Funds, among the best performing Israeli private equity funds, and provides a unique platform for facilitating the growth of Israeli companies into key emerging markets with a special focus on China.
The Life Sciences Corporate Finance arm of Cukierman & Co (CLA) provides investment banking services to private and public companies across the healthcare spectrum. These include Respinova, a treatment for COPD; TransAlgae, an Israeli biotech company that has developed an algae-based platform for oral delivery for Human Pharma (oral delivery technology replaces drug application by injection), Animal Health (oral delivery replaces the need for antibiotics and vaccinations by injection) and Crop Protection this application eliminates toxic chemical spraying to protect crops); Zmed-Laser, minimally invasive laser technologies for out-patient surgical procedures; AorticLab, medical and technological innovations developing next generation devices for transcatheter treatment of the stenotic aortic native valve; MSD, an international research biopharmaceutical company focusing on preventing and treating diseases including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases; and Orbimed, investing in innovations worldwide such as Amoy DX the leading cancer molecular diagnostics company in China.
Catalyst provides value-add to its portfolio companies – including a network of high caliber investors in markets across the US, Europe, China and Emerging-Markets, significant business networks and vast transactional experience in global capital markets and cross border M&A.
Over the past years more Chinese financial investors and strategic investors have focused on Israel. As the leading Israeli investment bank that prioritized China and Israel cross border transactions, Cukierman and Co assists Israeli technology companies to raise capital from China or to be acquired by Chinese corporates. Cukierman and Co now has offices in Shanghai, Changzhou, Singapore, in addition to its offices in France, Greece, Italy, Germany, Switzerland, and Mexico.
Edouard Cukierman is the Founder and Managing Partner of Catalyst Investments and serves as the Chairman of Cukierman & Co. Investment House. Since its establishment in 1993, Cukierman & Co. Investment House has been engaged in more than € 5.5 billion cross-border transactions across industries.
Learn more at https://cukierman.co.il/